175 related articles for article (PubMed ID: 33882093)
21. The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort.
Raffetti E; Postorino MC; Castelli F; Casari S; Castelnuovo F; Maggiolo F; Di Filippo E; D'Avino A; Gori A; Ladisa N; Di Pietro M; Sighinolfi L; Zacchi F; Torti C
BMC Public Health; 2016 Aug; 16(1):878. PubMed ID: 27557878
[TBL] [Abstract][Full Text] [Related]
22. Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy.
Masiá M; Padilla S; Álvarez D; López JC; Santos I; Soriano V; Hernández-Quero J; Santos J; Tural C; del Amo J; Gutiérrez F;
AIDS; 2013 Jan; 27(2):181-9. PubMed ID: 23018442
[TBL] [Abstract][Full Text] [Related]
23. Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock-inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors.
Kostaki EG; Limnaios S; Adamis G; Xylomenos G; Chini M; Mangafas N; Lazanas M; Patrinos S; Metallidis S; Tsachouridou O; Papastamopoulos V; Chatzidimitriou D; Antoniadou A; Papadopoulos A; Protopapas K; Tsiara C; Psichogiou M; Basoulis D; Pilalas D; Paraskeva D; Chrysos G; Paparizos V; Kourkounti S; Sambatakou H; Bolanos V; Sipsas NV; Lada M; Barbounakis E; Kantzilaki E; Panagopoulos P; Petrakis V; Drimis S; Katsarolis I; Lagiou P; Hatzakis A; Magiorkinis G; Skoura L; Paraskevis D
HIV Med; 2022 Dec; 23(11):1143-1152. PubMed ID: 36258653
[TBL] [Abstract][Full Text] [Related]
24. High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau - a cohort study from West Africa.
Hønge BL; Jespersen S; Aunsborg J; Mendes DV; Medina C; da Silva Té D; Laursen AL; Erikstrup C; Wejse C;
Pan Afr Med J; 2016; 25():40. PubMed ID: 28154729
[TBL] [Abstract][Full Text] [Related]
25. Effects of region of birth, educational level and age on late presentation among men who have sex with men newly diagnosed with HIV in a network of STI/HIV counselling and testing clinics in Spain.
Diaz A; del Romero J; Rodriguez C; Alastrue I; Belda J; Bru FJ; Cámara MM; Junquera ML; Sanz I; Viloria LJ; Gil L; Martínez E; Gual F; Landa MC; Pueyo I; Ureña JM; Martínez B; Varela JA; Polo A; Azpiri MA; Diez M;
Euro Surveill; 2015 Apr; 20(14):. PubMed ID: 25884148
[TBL] [Abstract][Full Text] [Related]
26. The high incidence of late presenters for HIV/AIDS infection in the Lodz province, Poland in the years 2009-2016: we are still far from the UNAIDS 90% target.
Wójcik-Cichy K; Jabłonowska O; Piekarska A; Jabłonowska E
AIDS Care; 2018 Dec; 30(12):1538-1541. PubMed ID: 29781305
[TBL] [Abstract][Full Text] [Related]
27. "Late for testing, early for antiretroviral therapy, less likely to die": results from a large HIV cohort study in China, 2006-2014.
Tang H; Mao Y; Tang W; Han J; Xu J; Li J
BMC Infect Dis; 2018 Jun; 18(1):272. PubMed ID: 29895275
[TBL] [Abstract][Full Text] [Related]
28. Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999-2013).
Wilton J; Light L; Gardner S; Rachlis B; Conway T; Cooper C; Cupido P; Kendall CE; Loutfy M; McGee F; Murray J; Lush J; Rachlis A; Wobeser W; Bacon J; Kroch AE; Gilbert M; Rourke SB; Burchell AN;
HIV Med; 2019 Feb; 20(2):110-120. PubMed ID: 30430742
[TBL] [Abstract][Full Text] [Related]
29. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
[TBL] [Abstract][Full Text] [Related]
30. The Population Impact of Late Presentation With Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America.
Belaunzarán-Zamudio PF; Caro-Vega YN; Shepherd BE; Rebeiro PF; Crabtree-Ramírez BE; Cortes CP; Grinsztejn B; Gotuzzo E; Mejia F; Padgett D; Pape JW; Rouzier V; Veloso V; Cardoso SW; McGowan CC; Sierra-Madero JG;
Am J Epidemiol; 2020 Jun; 189(6):564-572. PubMed ID: 31667488
[TBL] [Abstract][Full Text] [Related]
31. Recent infections among newly diagnosed cases of HIV infection in Spain, 2015-2016. National estimates using cohort data.
Hernando V; Cuevas MT; Pérez-Olmeda MT; Tasias M; Vera M; Jaen A; Mena A; Jarrin I; Diaz A;
Infect Dis (Lond); 2021 Jun; 53(6):440-449. PubMed ID: 33685324
[TBL] [Abstract][Full Text] [Related]
32. Cause-specific mortality among HIV-infected individuals, by CD4(+) cell count at HAART initiation, compared with HIV-uninfected individuals.
Wada N; Jacobson LP; Cohen M; French A; Phair J; Muñoz A
AIDS; 2014 Jan; 28(2):257-65. PubMed ID: 24105030
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the late presentation and associated factors of people living with HIV in Turkey.
Sevgi DY; Demirbas ND; Genc Yaman I; Derin O; Oncul A; Atasoy Tahtasakal C; Gul O; Diktas H; Dokmetas I
J Med Virol; 2023 May; 95(5):e28781. PubMed ID: 37212337
[TBL] [Abstract][Full Text] [Related]
34. Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord.
; Lodi S; Dray-Spira R; Touloumi G; Braun D; Teira R; D'Arminio Monforte A; Gallois A; Zangerle R; Spire B; Dabis F; Stähelin C; Termote M; Kirk O; Chêne G; Egger M; del Amo J
AIDS; 2014 Sep; 28(15):2297-306. PubMed ID: 25313585
[TBL] [Abstract][Full Text] [Related]
35. HIV medical care interruption among people living with HIV in Spain, 2004-2020.
Izquierdo R; Rava M; Moreno-García E; Blanco JR; Asensi V; Cervero M; Curran A; Rubio R; Iribarren JA; Jarrín I;
AIDS; 2023 Jul; 37(8):1277-1284. PubMed ID: 36939068
[TBL] [Abstract][Full Text] [Related]
36. Impact of late presentation on the risk of death among HIV-infected people in France (2003-2009).
Montlahuc C; Guiguet M; Abgrall S; Daneluzzi V; de Salvador F; Launay O; Martinez V; Partisani M; Pradier C; Rouveix E; Valin N; Grabar S; Costagliola D;
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):197-203. PubMed ID: 24047970
[TBL] [Abstract][Full Text] [Related]
37. [The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up].
Sobrino-Vegas P; Gutiérrez F; Berenguer J; Labarga P; García F; Alejos-Ferreras B; Muñoz MA; Moreno S; del Amo J;
Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):645-53. PubMed ID: 21820763
[TBL] [Abstract][Full Text] [Related]
38. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.
; Zwahlen M; Harris R; May M; Hogg R; Costagliola D; de Wolf F; Gill J; Fätkenheuer G; Lewden C; Saag M; Staszewski S; d'Arminio Monforte A; Casabona J; Lampe F; Justice A; von Wyl V; Egger M
Int J Epidemiol; 2009 Dec; 38(6):1624-33. PubMed ID: 19820106
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of late presentation for HIV treatment in a reference center in Belo Horizonte, Southeastern Brazil, from 2008 to 2010.
Valentini MB; Toledo ML; Fonseca MO; Thiersch LM; Toledo IS; Machado FC; Tupinambás U
Braz J Infect Dis; 2015; 19(3):253-62. PubMed ID: 25769736
[TBL] [Abstract][Full Text] [Related]
40. Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better.
Darling KE; Hachfeld A; Cavassini M; Kirk O; Furrer H; Wandeler G
Swiss Med Wkly; 2016; 146():w14348. PubMed ID: 27544642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
